Arcus Biosciences, Inc. Common Stock — Cash Flow (NYSE:RCUS) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 111.17 M-256.17 M438 M-306 M-170 M-482 M -488 M Cash from investing activities -434.37 M-3.87 M-413 M194 M-84 M66 M 148 M Cash from financing activities 438.68 M237.34 M33 M33 M277 M488 M 349 M Free cash flow 111.17 M-256.17 M438 M-306 M-170 M-484 M -489 M

News

Arcus Biosciences, Inc. (RCUS) Q1 2026 Earnings Call Transcript

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Beats Revenue Estimates

Eton Pharmaceuticals (ETON) Surges 19.8%: Is This an Indication of Further Gains?

Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Should You Buy?

Arcus Biosciences, Inc. (RCUS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Arcus Biosciences: TIGIT In The Rearview Mirror, Market Pricing A Bit Too Aggressively

Arcus Biosciences (RCUS) Moves 7.8% Higher: Will This Strength Last?

Arcus Biosciences at Leerink Conference: Casdatifan’s Promising Data

Arcus Biosciences: Q4 Beat And Casdatifan’s Story So Far (NYSE:RCUS)

Palantir, United Tech among market cap stock movers on Monday

Palantir and AeroVironment among market cap stock movers on Monday

Arcus Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation (NYSE:RCUS) 2026-02-27